Is Nuvalent, Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Nuvalent, Inc (NUVL) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Nuvalent, Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nuvalent, Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Nuvalent, Inc?

Muslim investors may consider investing in Nuvalent, Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Nuvalent, Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Nuvalent, Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Nuvalent, Inc updated?

The Shariah compliance status of Nuvalent, Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Nuvalent, Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Nuvalent, Inc?

You can check the latest Shariah compliance status of Nuvalent, Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NUVL Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 12, 2026

Report Source: 2026 1st Quarter Report

Nuvalent, Inc. Stock Analysis NUVL

United States Health Care Mid Cap Report: Q1, 2026

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 228 full-time employees. The company went IPO on 2021-07-29. The company develops small molecules that have the potential to overcome resistance, minimize adverse events, and address brain metastases. The company is advancing a robust pipeline with investigational candidates for ROS proto-oncogene 1 (ROS1)-positive, anaplastic lymphoma kinase (ALK)-positive, and human epidermal growth factor receptor 2 (HER2)-positive non-small cell lung cancer, and multiple discovery-stage research programs. Its product candidate, Zidesamtinib (NVL-520), is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC). NVL-520 is a novel ROS1-selective inhibitor. Its product candidate, Neladalkib (NVL-655), is being developed for patients with ALK-positive NSCLC. NVL-655 is a brain-penetrant ALK-selective inhibitor. Its product candidate, NVL-330, is a brain-penetrant HER2-selective inhibitor.

Key Statistics of Nuvalent, Inc (NUVL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$100.53$104.52

Today's Open

$103.52

Volume

798.51K

P/E Ratio (TTM)

52 Week Range

$68.64$113.02

Market Cap

8.01B

Avg. Volume

575.71K

Dividend Yield

Financial Metrics & Statements of Nuvalent, Inc (NUVL)

FAQ's for Nuvalent, Inc (NUVL)

According to Musaffa’s Shariah screening methodology, Nuvalent, Inc (NUVL) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.